CEO Executive AssistantSigning up for virtual EA support in pharmaceutical and biotech is a practical, low-friction process when you know what to prepare and which steps to take. For pharmaceutical and biotech CEOs who have already decided that EA support will improve how they operate, the goal is to move from decision to active support as efficiently as possible.
This guide walks you through the sign-up process with pharmaceutical-specific guidance at each step.
Before You Sign Up: Two Hours of Preparation
The difference between pharmaceutical CEOs who get maximum value from their EA support quickly and those who spend months in frustrating adjustment is almost always in what they did before the relationship started. Two hours of preparation before signing up creates the foundation for a productive relationship.
Prepare a Requirements Brief: Document the task categories you need support with, the hours per week you estimate each requires, and any pharmaceutical-specific context (regulatory calendar awareness, investor relations familiarity, confidentiality requirements). This brief goes to the service during the sign-up process and drives better matching.
Identify Your Non-Negotiables: What are the three to five things that absolutely must work for this relationship to be worth the investment? For most pharmaceutical CEOs, this includes: reliable availability during US business hours, professional-grade written communication, regulatory calendar awareness, and proper NDA protections. Know your non-negotiables before any conversation so you can verify them upfront.
Know Your Budget Range: Understand before signing up what monthly investment you are prepared to make and what service tier that corresponds to. Going into sign-up conversations without a budget position means the sales process controls you rather than the reverse.
Step 1: Select Two to Three Services to Evaluate
Do not sign up with the first service you encounter. Evaluate at least two to three options.
For pharmaceutical and biotech executives, the relevant services to consider are those that have demonstrated pharmaceutical client experience and can match you with an EA who has at least some pharmaceutical context awareness. Generic executive assistant services without pharmaceutical experience are a legitimate option, but verify that their matching process accounts for your industry-specific requirements.
Services commonly recommended for pharmaceutical executives include Boldly, Belay, and Prialto. For pharmaceutical-specialized boutique services, additional research into the current market is warranted, as this segment of the market evolves.
For a comprehensive comparison of services for pharmaceutical executives, see EA services for pharma. For a full overview of the best virtual EA options including dedicated models, dedicated EA for pharma covers that model specifically.
Step 2: Complete the Intake or Consultation Process
Most managed EA services require either a written intake form or a discovery consultation before matching begins. This is where your preparation pays off.
Share your requirements brief during the intake process. Be specific about your pharmaceutical context requirements: do you need an EA with FDA regulatory calendar familiarity? With pharmaceutical investor relations experience? With specific confidentiality handling experience?
The more specific you are, the more precisely the service can match you. Services that ask good follow-up questions about your pharmaceutical context are signaling that they take pharmaceutical client matching seriously. Services that proceed without asking are not.
Step 3: Review and Negotiate the Service Agreement
Before signing any service agreement, review these specific terms.
Scope Definition: Is the scope of services clear? Does it include the specific task categories you need?
Hours and Overage: How many hours are included? What is the overage rate for additional hours?
Response Time SLA: What response time commitments does the service make in writing? For pharmaceutical CEO support, same-day response for routine requests and 1 to 2 hour response for urgent requests is the appropriate standard.
Replacement Guarantee: What is the specific replacement turnaround time? Is it guaranteed in writing?
NDA and Confidentiality Terms: Are the confidentiality terms adequate for pharmaceutical-specific information? If not, negotiate additions with your legal team before signing.
Exit Terms: What is the notice period if you decide to end the arrangement? Month-to-month is standard; understand what you are committing to.
Step 4: Execute Confidentiality Documentation
Before your EA accesses any information about your pharmaceutical operation, execute proper confidentiality documentation.
For managed services, their standard NDA governs the relationship. Review it carefully and add any pharmaceutical-specific riders your legal team requires. For direct-hire arrangements, work with your legal team to execute an appropriate NDA before the EA begins work.
Also prepare a data handling protocol (typically one page) that defines what information your EA will encounter, what systems they can access, and how they should handle requests for information they are uncertain about.
Step 5: Provision Access and Set Up Communication Systems
Once agreements are signed and your EA start date is confirmed, provision the access they need.
Calendar Access: Your EA needs access to your calendar with the appropriate permission level (typically full editing access for scheduling management).
Email Access: Define the email account access and permission level. This may be read access with drafting capability, or full access depending on your comfort level.
Document Management: Access to document storage systems relevant to their function (travel booking tools, board document repositories, investor tracking systems) with minimum necessary permissions.
Communication Channels: Define how you and your EA will communicate. Slack or Teams for routine communication, text or direct call for urgent requests, email for formal documentation.
Step 6: Onboard with a Structured Briefing
Your EA’s first day should begin with a structured briefing, not a task list. Invest 90 minutes to two hours on the first day in walking your EA through:
- Your regulatory calendar for the next 12 months
- The five to ten most important external stakeholders with context on each
- Your communication standards with examples
- Your scheduling preferences in specific detail
- The information handling protocols from your confidentiality framework
Research from McKinsey confirms that onboarding investment is the strongest predictor of early EA relationship effectiveness. Pharmaceutical executives who invest in structured onboarding reach full EA productivity significantly faster than those who expect an EA to figure out the context independently.
What to Expect After Signing Up
Week 1: Administrative setup, calibration tasks, and norm-setting. Expect some adjustment and provide active feedback.
Weeks 2 to 4: First full cycle of ongoing support. Your EA develops rhythm with your calendar and communications patterns.
Month 2: Meaningful time recovery begins as your EA handles tasks independently. The relationship reaches operational value.
Months 3 to 6: Deep context accumulation. Your EA begins anticipating needs and managing proactively rather than reactively.
Conclusion
Signing up for virtual EA support in pharmaceutical and biotech is a straightforward process when you prepare requirements in advance, select services with pharmaceutical client experience, review service agreements specifically for pharmaceutical CEO context, execute proper confidentiality documentation, and invest in a structured onboarding. The two hours of preparation you invest before signing up shapes the entire quality of the relationship that follows. Do it deliberately.
Related Reading
For further context, explore Sign Up for Virtual EA Support in Automotive and Sign Up for Virtual EA Support in Construction & Architecture.